USP – Combating Substandard & Counterfeit Medicines

USP: Over the past few decades, the supply chain for pharmaceuticals and their ingredients has expanded around the world, and so has the presence of substandard and counterfeit products. Notable adverse events related to poor quality medicines (e.g., heparin and glycerin contamination) have brought increased attention from policymakers, regulators, manufacturers, and Read more…

PRESS RELEASE: Ten global health organizations united in a worldwide campaign, November 2013

To download this press release from Fight the Fakes click here. Embargoed until 26 November 2013 (7:00 CET) Ten global health organizations united in a worldwide campaign to protect patients from fake medicines Fake medicines put patients and the general public at risk. Patients believe they are receiving genuine treatment, but Read more…